ROYAL BANK OF CANADA - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$144,000
-64.7%
1,675
-61.7%
0.00%
Q2 2023$408,000
-0.2%
4,377
+1.2%
0.00%
Q1 2023$409,000
-10.1%
4,326
-4.6%
0.00%
Q4 2022$455,000
+27.1%
4,533
+8.5%
0.00%
Q3 2022$358,000
+3.2%
4,178
+3.4%
0.00%
Q2 2022$347,000
-11.7%
4,039
-7.6%
0.00%
Q1 2022$393,000
-22.2%
4,373
-13.4%
0.00%
Q4 2021$505,000
+16.1%
5,050
+8.0%
0.00%
Q3 2021$435,000
+20.2%
4,676
+9.9%
0.00%
Q2 2021$362,000
+59.5%
4,254
+62.1%
0.00%
Q1 2021$227,000
+14.1%
2,625
+10.9%
0.00%
Q4 2020$199,000
+116.3%
2,366
+105.4%
0.00%
Q3 2020$92,000
+15.0%
1,152
+28.0%
0.00%
Q2 2020$80,000
-5.9%
9000.0%0.00%
Q1 2020$85,000
-32.5%
900
-22.9%
0.00%
Q4 2019$126,000
+46.5%
1,167
+29.7%
0.00%
Q3 2019$86,000
-10.4%
900
-10.0%
0.00%
Q2 2019$96,000
+9.1%
1,0000.0%0.00%
Q1 2019$88,000
+6.0%
1,0000.0%0.00%
Q4 2018$83,000
-18.6%
1,000
-7.5%
0.00%
Q3 2018$102,000
-7.3%
1,081
+8.1%
0.00%
Q2 2018$110,000
+11.1%
1,0000.0%0.00%
Q1 2018$99,000
+19.3%
1,000
-2.8%
0.00%
Q4 2017$83,000
-14.4%
1,029
-22.0%
0.00%
Q3 2017$97,000
+16.9%
1,319
+14.7%
0.00%
Q2 2017$83,000
-5.7%
1,150
-18.3%
0.00%
Q1 2017$88,000
+183.9%
1,407
+225.7%
0.00%
Q4 2016$31,000
+14.8%
432
-4.0%
0.00%
Q3 2016$27,000
+68.8%
450
+80.0%
0.00%
Q2 2016$16,0000.0%2500.0%0.00%
Q1 2016$16,000
+6.7%
250
-4.9%
0.00%
Q4 2015$15,000
-34.8%
263
-39.5%
0.00%
Q3 2015$23,000
-32.4%
435
-24.6%
0.00%
Q2 2015$34,000
+100.0%
577
+108.3%
0.00%
Q1 2015$17,000
+13.3%
277
+10.8%
0.00%
Q4 2014$15,000
+25.0%
2500.0%0.00%
Q3 2014$12,000
-20.0%
250
-16.7%
0.00%
Q2 2014$15,000
-11.8%
3000.0%0.00%
Q1 2014$17,000
-26.1%
300
-25.0%
0.00%
Q4 2013$23,000
-23.3%
400
-19.7%
0.00%
Q3 2013$30,000
+36.4%
498
+24.5%
0.00%
Q2 2013$22,0004000.00%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders